Efficacy of fibrine glue on seroma formation after lymph nodes D2 dissection

Efficacy of fibrine glue on seroma formation after lymph nodes D2 dissection in gastric cancer surgery

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200710048071N1

Enrollment

Registered

2020-08-16

Start date

2020-06-30

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer. Malignant neoplasm of stomach

Interventions

Intervention 1: Intervention group:In this group, after D2 lymphatic dissection, 0.5 ml of fibrine glue (IFABOND, Peters Surgical,Bobigny,France) is injected into the dissected area, and seroma forma

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with gastric cancer are candidates for gastrectomy,hospitalized in 1399

Exclusion criteria

Exclusion criteria: Patients with a history of surgery, patients with dissatisfaction with the study, patients with any local allergy to fibrin glue, patients in the metastatic stage of cancer

Design outcomes

Primary

Measure	Time frame
Seroma formation. Timepoint: Measurement of drainage (seroma) on a daily basis until discharge of patients. Method of measurement: Drain rate (ml / 24 hours).	—

Secondary

Measure	Time frame
Number of days hospitalized. Timepoint: Duration of hospitalization. Method of measurement: Days of hospitalization.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEhsanollah Rahimi Movaghar

Tehran University of Medical Sciences

ehsanrm81@gmail.com+98 21 2265 9074

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 15, 2026